Accrued liabilities included the following: | | | | | | | | | AS OF MAY 31, | (Dollars in millions) | 2019 | 2018 | Compensation and benefits, excluding taxes | $ | 1,232 |
| $ | 897 |
| Sales-related reserves(1) | 1,218 |
| 20 |
| Endorsement compensation | 424 |
| 425 |
| Dividends payable | 346 |
| 320 |
| Import and logistics costs | 296 |
| 268 |
| Collateral received from counterparties to hedging instruments | 289 |
| 23 |
| Taxes other than income taxes payable | 234 |
| 224 |
| Advertising and marketing | 114 |
| 140 |
| Fair value of derivatives | 52 |
| 184 |
| Other(2) | 805 |
| 768 |
| TOTAL ACCRUED LIABILITIES | $ | 5,010 |
| $ | 3,269 |
|
| | (1) | Sales-related reserves as of May 31, 2019 reflect the Company's fiscal 2019 adoption of Topic 606. As of May 31, 2018, Sales-related reserves reflect the Company's prior accounting under Topic 605. Refer to Note 1 — Summary of Significant Accounting Policies for additional information on the adoption of the new standard. |
| | (2) | Other consists of various accrued expenses with no individual item accounting for more than 5% of the total Accrued liabilities balance at May 31, 2019 and 2018. |
|